Department of Nutrition, Faculty of Medicine, University of Chile, Independencia 1027, Casilla, Santiago 70000, Chile.
Department of Nutrition, Faculty of Medicine, University of Chile, Independencia 1027, Casilla, Santiago 70000, Chile.
Prostaglandins Leukot Essent Fatty Acids. 2020 Feb;153:102058. doi: 10.1016/j.plefa.2020.102058. Epub 2020 Jan 22.
The administration of iron induces liver oxidative stress and depletion of long-chain polyunsaturated fatty acids (LCPUFAs), n-6/n-3 LCPUFA ratio enhancement and fat accumulation, which may be prevented by antioxidant-rich extra virgin olive oil (AR-EVOO) supplementation. Male Wistar rats were subjected to a control diet (50 mg iron/kg diet) or iron-rich diet (IRD; 200 mg/kg diet) with alternate AR-EVOO for 21 days. Liver fatty acid (FA) analysis was performed by gas-liquid chromatography (GLC) after lipid extraction and fractionation, besides Δ-5 desaturase (Δ-5 D) and Δ6-D mRNA expression (qPCR) and activity (GLC) measurements. The IRD significantly (p < 0.05) increased hepatic total fat, triacylglycerols, free FA contents and serum transaminases levels, with diminution in those of n-6 and n-3 LCPUFAs, higher n-6/n-3 ratios, lower unsaturation index and Δ5-D and Δ6-D activities, whereas the mRNA expression of both desaturases was enhanced over control values, changes that were prevented by concomitant AR-EVOO supplementation. N-6 and n-3 LCPUFAs were also decreased by IRD in extrahepatic tissues and normalized by AR-EVOO. In conclusion, AR-EVOO supplementation prevents IRD-induced changes in parameters related to liver FA metabolism and steatosis, an effect that may have a significant impact in the treatment of iron-related pathologies or metabolic disorders such as non-alcoholic fatty liver disease.
铁的摄入会导致肝脏氧化应激和长链多不饱和脂肪酸(LCPUFAs)的消耗,n-6/n-3 LCPUFA 比例增加和脂肪堆积,而富含抗氧化剂的特级初榨橄榄油(AR-EVOO)补充可能会预防这种情况。雄性 Wistar 大鼠接受对照饮食(50mg 铁/千克饮食)或富含铁的饮食(IRD;200mg 铁/千克饮食),并交替补充 AR-EVOO 21 天。在脂质提取和分级后,通过气相色谱(GLC)进行肝脏脂肪酸(FA)分析,此外还进行了 Δ-5 去饱和酶(Δ-5D)和 Δ6-D mRNA 表达(qPCR)和活性(GLC)测量。IRD 显著(p<0.05)增加了肝总脂肪、三酰甘油、游离 FA 含量和血清转氨酶水平,同时降低了 n-6 和 n-3 LCPUFA、更高的 n-6/n-3 比例、更低的不饱和指数和 Δ5-D 和 Δ6-D 活性,而两种去饱和酶的 mRNA 表达均高于对照值,这些变化被同时补充 AR-EVOO 所预防。IRD 还降低了肝外组织中的 n-6 和 n-3 LCPUFA,并通过 AR-EVOO 使其正常化。总之,AR-EVOO 补充可预防 IRD 引起的与肝脏 FA 代谢和脂肪变性相关的参数变化,这种作用可能对治疗与铁相关的病理或代谢紊乱(如非酒精性脂肪肝疾病)具有重要影响。